By Kamran Zamanian, Ph.D, and Sean Collins, iData Research Inc.

Growth of the United States’ elderly population has driven a steady increase in the number of patients requiring treatment for peripheral vascular lesions. Meanwhile, the availability of increasingly sophisticated technology has improved patient outcomes and broadened the range of patient anatomies that can be endovascularly treated. The subsequent rise in procedural volume has applied upward pressure on the value of the U.S. market for peripheral vascular devices.

The U.S. Peripheral Vascular Device Market Shifting Demographics, Technological Innovation Fueling Growth 1

Peripheral Vascular Device Market By Segment, U.S., 2012 To 2022

Demographic Shift Increases Treatment Demand

Peripheral arterial disease (PAD) is characterized by the buildup of plaque on the inner walls of the arteries carrying blood from the heart to the legs, arms, stomach, or kidneys. PAD represents a leading source of demand in the U.S. peripheral vascular device market. Roughly 10 million Americans are estimated to be affected by PAD2. The most common endovascular treatments for PAD include stenting, balloon angioplasty, and atherectomy; the combined markets for the devices utilized in peripheral stenting, balloon angioplasty, and atherectomy procedures represented approximately…